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5.1  Introduction
Infertility is a worldwide growing issue, and female factors account for about 30 % 
of the total cases of infertility. The majority of couples affected by infertility undergo 
in vitro fertilization (IVF) protocols following women hormonal hyperstimulation 
cycles to obtain mature oocytes to fertilize in vitro. Nowadays, the oocyte/embryo 
quality is mainly assessed by morphokinetic parameters even if these approaches 
have low objective prediction value. The rate of live newborns after IVF is relatively 
low, ranging from about 30 % in younger women to 10 % in the older ones. Aging, 
in fact, is a well-known critical factor for the success of IVF protocols. As a conse-
quence, a primary goal in older women is to increase the pregnancy rate, with a 
crucial point represented by the selection of the oocytes to fertilize in vitro and 
transfer in women.
In this view, transcriptomic information about granulosa cells (GCs) might shed 
light on the oocyte viability, thereby providing a non-invasive method of oocyte/
embryo selection.
The nutritional support and trafficking of macromolecules that this system allows 
may be particularly important for oocytes due to the avascular nature of the granu-
lose layer [1]. The signaling between GCs and oocyte via cytoplasmic processes 
penetrating the zona pellucid and forming gap junctions at the oocyte surface is a 
key means of disseminating local and endocrine signals to the oocyte [2]. In fact, 
GCs functionality is a key determinant of the oocyte quality and competence, since 
GCs are the somatic cells strictly connected to the growing oocyte by a bidirectional 
communication ensuring the environment for its correct development. It is clear that 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
the role of the oocyte extends far beyond its functions in the transmission of genetic 
information and supply of raw materials to the early embryo. It also has a critical 
part to play in mammalian follicular control and the regulation of oogenesis, ovula-
tion rate, and fecundity [3, 4].
This chapter is aimed to explore the GCs gene activity in physiological and path-
ological conditions.
5.2  Gene Modulation of Granulosa Cells During 
Folliculogenesis
The ovarian follicle development is a complex process involving the coordination of 
many factors that regulate the growth and differentiation of the female gamete and 
the surrounding somatic components.
Follicular development starts from a pool of inactive primordial follicles. 
Primordial follicles are generated from primordial germ cells (PGs) and surround-
ing undifferentiated somatic cells that migrate to the genital ridge where they 
undergo mitosis cycles creating the germ cell cyst. This process is under the control 
of many factors such as BMPs, NANOG, OCT4, and FIGα.
Following the germ cell cyst, mitosis is arrested and germ cells start meiosis giv-
ing rise to the primary oocytes. Primary oocyte and somatic cells form the primor-
dial follicle in which oocytes arrest in the diktyate stage of meiosis I and are 
surrounded by primordial GCs. This process is regulated by estrogens and a number 
of growth factors (Ttf and GEFF) and protein (FOXL2 and NOBOX). The activa-
tion of primordial follicles to develop in primary follicles is a dynamic process 
strictly controlled by PI3K/AKT pathway. Primordial follicles are the total germ 
cells reservoir of a woman and are continuously activated during the entire life to 
initiate the folliculogenesis. The expression of two oocyte factors (SOHLH1 and 
NOBOX) is crucial for primordial follicles activation and progression to the pri-
mary follicle. During this stage, the oocytes grow and the surrounding GCs begin 
mitotic divisions. The number of GCs increases as well as the number of cuboidal 
GCs layers around the oocyte, and the basal lamina expands. GCs express anti- 
Mullerian hormone (AMH) to control the number of primordial follicles being 
active. Primary follicles turn into secondary follicles under the control of local intra- 
ovarian factors produced by oocyte and GCs, such as GDF9 and BMP15. The early 
stages of follicular development are hormones-independent even if GCs express the 
stimulating hormone receptors (FSHR). Intra-ovarian paracrine factors play their 
role also during the formation of pre-antral follicle, but the expression of receptors 
for FSH and LH demonstrates that the follicles become sensitive to gonadotropins 
at this stage. During the formation of antral follicles, GCs show high proliferative 
capacity, giving rise to the particular antral multi-layer structure, forming the antral 
cavity. Many factors are involved in these phases of follicular development includ-
ing Activin-A and Inhibinα. During the antral stage, GCs create the complex net-
work of interaction with oocyte and the other GCs by GAP junctions that are 
essential for cellular communications during all phases of follicular development. 
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Finally, the antral follicle reaches its late stage with the formation of antrum, and 
GCs differentiate into mural cells (MCs) and cumulus cells (CCs). MCs surround 
the wall of the follicles and are mainly involved in steroidogenic function, while 
CCs remain strictly associated to oocyte creating particular gap junctions in a spe-
cialized structure, namely, the cumulus-oocyte complex (COC). This particular 
structure allows the oocyte to acquire the competence to continue meiotic division 
and the capability to be fertilized. MCs and CCs are differentially regulated by 
oocyte factors and LH activity, and in particular, oocytes regulate the CCs metabolic 
activity. Gap junctions are extremely important for the bidirectional communica-
tions between oocyte and CCs, which are physically separated by the zona pellu-
cida. These highly specialized junctions allow the passage of many molecules from 
CCs to oocyte, such as amino acids and metabolites, and their activity is essential to 
oocyte development and competence. During the ovulation process, CCs expansion 
is regulated both by oocyte and LH activity [5].
Many pathways have been reported to be activated in the inter-communications 
between GCs and oocyte, and it is known that alterations in GCs are responsible for 
oocyte maturation arrest or low quality. The deregulation of GCs translates into fol-
licle microenvironment disruption with oocyte competence and maturation altera-
tions. Furthermore, GCs alterations have been linked to women infertility 
phenotypes. Transcriptomic analysis of GCs could thus be useful to uncover new 
biomarkers of oocyte quality and competence [6].
5.3  Granulosa Cells Transcriptome Analysis
Given the intimate connection between GCs and oocyte, it is clear that modifica-
tions in somatic components transcriptomes affect the oocyte functions and vice 
versa. The main approaches employed to study GCs transcriptome have been repre-
sented by microarray analysis and next-generation RNA sequencing [7]. These two 
approaches allow to study simultaneously thousands of transcripts and evidence the 
role of specific genes in normal and pathological oocyte development. Studies per-
formed by using these tools confirmed the role of GCs in steroidogenic function and 
others processes such as inter-cellular communication and follicle matrix forma-
tion, distinguishing the genes selectively expressed by MCs or CCs. Gene expres-
sion analyses of GCs in aging women or women with reduced ovarian reserve are of 
particular interest. They showed the altered expression of key genes involved in 
glycolytic pathway producing lower levels of progesterone. These conditions could 
be associated to the inability of GCs to differentiate into mature CCs or to the 
diminished quality of the oocyte unable to secrete the paracrine factors for GCs dif-
ferentiation. The increased female age seems to be the most important factor affect-
ing GCs gene expression. Furthermore, GCs transcriptome was reported to be 
affected by the oocyte aneuploidy, reducing transcriptional activity of the somatic 
components [8].
GCs gene expression analysis is also useful to differentiate oocyte at a different 
stage of maturation. The processes mainly modulated by GCs during oocyte 
5 Gene Expression in Cumulus Cells and Oocyte Quality
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
maturation resulted in the mitogen-activated protein kinase pathway, the lipid bio-
synsthesis and apoptosis. ANG (angiogenin), PLIN2 (perilipin 2), and RGS2 were 
indicated as three potential biomarkers of oocyte maturation stage [9].
5.4  Granulosa Cells Transcriptome Analysis: The Ovarian 
Stimulation Effect
Controlled ovarian stimulation (COS) used during assisted reproductive protocols 
has been indicated as a modifying factor of GCs transcriptome. Many studies 
reported that ovarian stimulations are able to alter normal CCs gene expression, thus 
affecting oocyte maturation and competence. In particular, we demonstrated that 
r-hLH + r-hFSH and hp-hMG modulate the gene expression of CCs [10]. Probably, 
the effect of the two preparations at the intracellular level is mediated by different 
binding affinity of the two molecules with the same receptor, leading in turn to the 
activation of different pathways. The two treatments differentially alter gene tran-
scription of molecules involved in the trafficking of retinoic acid and ovarian ste-
roidogenesis (RXRB, TTR, ALDH8A1) and follicular development (IL11; AKT3). 
Few studies analyzed GCs transcriptome modulation by different hormonal stimu-
lations. Recently, Borgbo and colleagues explored the differences in follicle tran-
scriptomes in patients treated with hCG or GnRH by high-density microarray 
approach. The authors reported that CCs have a higher LHR expression in GnRHa- 
triggered follicles as compared with hCG-triggered follicles while MCs showed the 
differentially expression of genes like ANGPT1 and SEMA3A, suggesting an 
impaired induction of angiogenesis [11].
These data demonstrate that GCs, and in particular CCs, analyses could be highly 
informative about oocyte developmental competence. They could represent a new 
attractive non-invasive biomarker of oocyte quality. Potential candidate genes, 
expressed by GCs, which could be used as markers of oocyte quality, are hyaluro-
nan synthase 2 (HAS2), inhibin betaA (INHBA), epidermal growth factor receptor 
(EGFR), gremlin 1 (GREM1), betacellulin (BTC), CD44, tumor necrosis factor- 
induced protein 6 (TNFAIP6), and prostaglandin endoperoxide synthase 2 (PTGS2).
5.5  Granulosa Cells Transcriptome Analysis: Polycystic 
Ovarian Syndrome
The data from all of the reviewed investigations showed that the transcriptomic 
behavior of follicular cells is influenced by a number of variables including body 
mass index (BMI), serum FSH level and female age, IVF stimulation protocols and 
disorders. Different studies have been reported a specific gene expression modula-
tion on the follicular cells in patients with polycystic ovarian syndrome (PCOS). 
PCOS is the most common disorder in women of reproductive age, affecting 7 % of 
the female population. PCOS shows heterogeneous features characterized by abnor-
mal folliculogenesis. The influence of PCOS on the follicular environment of 
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maturing oocytes was assessed by Haouzi et al. [12]. The expression patterns 
between PCOS patients and control group were significantly different, and multiple 
genes were affected by PCOS. The members of the growth factor family include 
EGFR, EREG, and AREG and others known to regulate steroid metabolism such as 
CYP11A1. The authors postulated that the reduced oocyte competence seen in 
PCOS patients could be due to incorrect functioning of the Ttf and estrogen recep-
tors signaling cascades.
The central stroma and the granulosa cells were indicated as two possible ovarian 
sites of the pathophysiological changes in PCOS [13]. It was reported that follicular 
development disorders in PCOS were mainly related to GCs apoptosis, in associa-
tion with the increased oxidative stress and reactive oxygen species generation. 
PCOS transcriptome microarray studies have been performed on whole cultured 
theca cells, oocytes, and cumulus cells from hyperstimulated and luteinized folli-
cles. Recently, Schmith and colleagues performed an interesting study on ovarian 
tissue in PCOS patients, where GC and the ovarian central stroma were examined 
separately. A low-density gene array approach, followed by a real-time PCR valida-
tion, was employed to analyze the gene expression in both the central ovarian stroma 
and in GCs from control and PCOS women. The results showed in the central 
stroma of PCOS ovaries the down-regulation of five inflammation-related genes 
(CCL2, IL1R1, IL8, NOS2, TIMP1), the leukocyte marker CD45, the inflammation- 
related transcription factor RUNX2 and the growth factor AREG. The growth factor 
DUSP12 and the coagulation factor TFPI2 were instead over-expressed. On the 
other hand, PCOS GCs showed the over-regulation of the inflammation-related 
IL1B, IL8, LIF, NOS2, and PTGS2; the coagulation-related F3 and THBS1; the 
growth factors BMP6 and DUSP12; the permeability-related AQ3; and the growth 
arrest-related GADD45A. These data suggested the activation of pro-inflammatory 
genes in PCOS GCs, which could be validated as markers of follicle maturation 
defects and predictors of oocyte competence.
 Conclusions
The development of non-invasive oocyte assessments, based on the transcrip-
tomic analysis of GCs, is likely to be of clinical as well as of scientific value. The 
accurate identification of oocytes that are both chromosomally normal and com-
petent to support early preimplantation development could revolutionize 
IVF. The data showed suggest that competent oocytes develop in a follicular 
environment in which processes such as steroidogenesis, cell-cell communica-
tion and signaling, metabolism and transport are active. However, this is influ-
enced by a variety of factors. These include the stage of maturation of the 
developing oocyte, the type of COS employed during IVF and the chromosome 
constitution of the oocyte.
In conclusion, the improvement of new transcriptomic technologies such as 
Next Generation Sequencing (RNA-seq) could shed light on the granulosa cells 
molecular pathways. Nowadays, this technology is not so frequently used com-
pared to microarrays due to its high cost and complex bioinformatic analysis. In 
any case, these platforms produce a throughput per run that is higher by several 
[AU1]
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orders of magnitude versus classical approaches and important discoveries in the 
field of physiology and/or pathophysiology. These data could be useful to unravel 
the key genes regulating follicular maturation in physiological and pathological 
conditions. The use of quantitative gene expression measurements on granulosa 
cells, which are in close contact with the oocyte during growth and maturation, 
seems a promising method to predict oocyte quality and competence.
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